Nvidia Reveals Updated Equity Portfolio
Nvidia (NASDAQ: NVDA) has provided an update on its equity portfolio, which is now valued at about $63.4 billion as of June 30, 2026, according to a recent Form 13F filing.
The filing shows a significant increase from last quarter, when the portfolio value was around $18.4 billion, largely due to the growth of existing investments and a new substantial position in SpaceX (NASDAQ: SPCX).
A closer look at the investments reveals that Intel (NASDAQ: INTC) continues to be the largest component of Nvidia’s stock portfolio. At the close of the second quarter, Nvidia held 214.8 million shares of Intel, valued at roughly $30 billion, which makes up about 44.23% of its disclosed portfolio.
This stake was initially established through a $5 billion investment announced in 2025, forming part of a partnership aimed at creating chips for computers and data centers.
However, compared to the previous quarter, Intel’s share in the portfolio has diminished from 51.58%, although its market value has increased.
The most notable change in Nvidia’s holdings is the addition of SpaceX. Nvidia now owns 122.8 million Class A shares of SpaceX, valued around $21 billion, accounting for 30.94% of its overall portfolio. This is particularly interesting as it’s the first time SpaceX has publicly disclosed the value of its stock since its market debut.
Nvidia’s Connection to Musk’s Ventures
This new investment aligns with Nvidia’s earlier funding of Elon Musk’s xAI. Following SpaceX’s acquisition of xAI and its market introduction, this has emerged as one of Nvidia’s key assets.
Besides Intel and SpaceX, Nvidia maintains significant positions in the artificial intelligence and semiconductor sectors. CoreWeave stands as the third largest holding, valued at about $4.7 billion, making up 6.93% of the portfolio. Nebius Group (NASDAQ: NBIS) closely follows with around $4.69 billion and 6.91%.
Other important investments include Coherent (NYSE: COHR) at approximately $3.07 billion, Nokia at $2.21 billion, and Synopsys (NASDAQ: SNPS) at $2.15 billion. Nvidia has also reported a minor stake in Generate Biomedicines (NASDAQ: GENB) valued at about $14 million.
The most recent filing indicates a highly concentrated portfolio, with Intel and SpaceX together making up over 75% of total disclosed investments.
It’s worth noting that while the filing captures the situation as of June 30, circumstances have shifted since that date. SpaceX shares have dropped from the valuation used in the filing, and Intel’s stock has also declined from its quarter-end price, impacting the current value of their holdings.
